These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12818746)

  • 21. A demand-side view of risk adjustment.
    Feldman R; Dowd BE; Maciejewski M
    Inquiry; 2001; 38(3):280-9. PubMed ID: 11761355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-adjusted capitation: recent experiences in The Netherlands.
    van de Ven WP; van Vliet RC; van Barneveld EM; Lamers LM
    Health Aff (Millwood); 1994; 13(5):120-36. PubMed ID: 7868016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health plans and selection: formal risk adjustment vs. market design and contracts.
    Frank RG; Rosenthal MB
    Inquiry; 2001; 38(3):290-8. PubMed ID: 11761356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competition under a regime of imperfect risk adjustment: the Swiss experience.
    Beck K
    Soz Praventivmed; 1998; 43(1):7-8. PubMed ID: 9544465
    [No Abstract]   [Full Text] [Related]  

  • 26. Health-based risk adjustment: is inpatient and outpatient diagnostic information sufficient?
    Lamers LM
    Inquiry; 2001-2002 Winter; 38(4):423-31. PubMed ID: 11887959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forming and reforming the market for third-party purchasing of health care: a German perspective.
    Graf von der Schulenburg JM
    Soc Sci Med; 1994 Nov; 39(10):1473-81. PubMed ID: 7863359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supervision in social health insurance: a four country study.
    Maarse H; Paulus A; Kuiper G
    Health Policy; 2005 Mar; 71(3):333-46. PubMed ID: 15694500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cream-skimming in deregulated social health insurance: evidence from Switzerland.
    Beck K; Zweifel P
    Dev Health Econ Public Policy; 1998; 6():211-27. PubMed ID: 10662405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the sickness funds in the Belgian health care market.
    Nonneman W; van Doorslaer E
    Soc Sci Med; 1994 Nov; 39(10):1483-95. PubMed ID: 7863360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.
    Lamers LM
    Health Policy; 1998 Jul; 45(1):15-32. PubMed ID: 10183010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demand-side strategies to deal with moral hazard in public insurance for long-term care.
    Bakx P; Chernichovsky D; Paolucci F; Schokkaert E; Trottmann M; Wasem J; Schut F
    J Health Serv Res Policy; 2015 Jul; 20(3):170-6. PubMed ID: 25770020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk-adjusted capitation based on the Diagnostic Cost Group Model: an empirical evaluation with health survey information.
    Lamers LM
    Health Serv Res; 1999 Feb; 33(6):1727-44. PubMed ID: 10029506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Switching sickness funds and risk compensation mechanisms in the statutory health insurance system in Germany--empirical results from the cooperative health research in the region of Augsburg (KORA)].
    Werner A; Reitmeir P; John J
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S158-66. PubMed ID: 16032535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mandatory pooling as a supplement to risk-adjusted capitation payments in a competitive health insurance market.
    Van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    Soc Sci Med; 1998 Jul; 47(2):223-32. PubMed ID: 9720641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the calculation of the Israeli risk adjustment rates.
    Shmueli A
    Eur J Health Econ; 2015 Apr; 16(3):271-7. PubMed ID: 24577558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. German risk structure compensation: enhancing equity and effectiveness.
    Files A; Murray M
    Inquiry; 1995; 32(3):300-9. PubMed ID: 7591043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How profitable is risk selection? A comparison of four risk adjustment models.
    Shen Y; Ellis RP
    Health Econ; 2002 Mar; 11(2):165-74. PubMed ID: 11921314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managed competition in California's small-group insurance market.
    Buchmueller TC
    Health Aff (Millwood); 1997; 16(2):218-28. PubMed ID: 9086671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.